346
Views
84
CrossRef citations to date
0
Altmetric
Original Articles

Genetic Polymorphisms in MTHFR 677 and 1298, GSTM1 and T1, and Metabolism of Arsenic

, , , , , , , , , & show all
Pages 159-170 | Published online: 24 Feb 2007

REFERENCES

  • Adonis, M., Martinez, V., Marin, P., and Gil, L, 2005. CYP1A1 and GSTM1 genetic polymorphisms in ling cancer populations exposed to arsenic in drinking water, Xenobiotica 35 (2005), pp. 519–530, [INFOTRIEVE][CSA].
  • Aposhian, H. V., Zakharyan, R. A., Avram, M. D., Sampayo-Reyes, A., and Wollenberg, M, 2004. A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxification of trivalent arsenic species, Toxicol. Appl. Pharmacol 198 (2004), pp. 327–335, [INFOTRIEVE][CSA].
  • Bates, M., Rey, O., Biggs, M., Hopenhayn, C., Moore, L., Kalman, D., Steinmaus, C., and Smith, A, 2004. Case-control study of bladder cancer and exposure to arsenic in Argentina, Am. J. Epidemiol 159 (2004), pp. 381–389, [INFOTRIEVE][CSA].
  • Bernstam, L., and Nriagu, J. O, 2000. Molecular aspects of arsenic stress, J. Toxicol. Environ. Health B 3 (2000), pp. 293–322, [CSA].
  • Brouwer, O. F., Onkenhout, W., Edelbroek, P. M., de Kom, J. F., de Wolff, F. A., and Peters, A. C, 1992. Increased neurotoxicity of arsenic in methylenetetrahydrofolate reductase deficiency, Clin. Neurol. Neurosurg 94 (1992), pp. 307–310, [INFOTRIEVE][CSA].
  • Brown, K., Kluijtmans, L., Young, I., Murray, L., McMaster, D., Woodside, J., Yarnell, J., Boreham, C., McNulty, H., Strain, J., McPartlin, J., Scott, J., Mitchell, L., and Whitehead, A, 2004. The 5,10-methylenetetrahydrofolate reductase C677T polymorphism interacts with smoking to increase homocysteine, Atherosclerosis 174 (2004), pp. 315–322, [INFOTRIEVE][CSA].
  • Buchet, J. P., and Lauwerys, R, 1985. Study of inorganic arsenic methylation by rat liver in vitro: Relevance for the interpretation of observations in man, Arch. Toxicol 57 (1985), pp. 125–129, [INFOTRIEVE][CSA].
  • Buchet, J. P., and Lauwerys, R, 1987. Study of factors influencing the in vivo methylation of inorganic arsenic in rats, Toxicol. Appl. Pharmacol 91 (1987), pp. 65–74, [INFOTRIEVE][CSA].
  • Buchet, J. P., Lauwerys, R., and Roels, H, 1981a. Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in man, Int. Arch. Occup. Environ. Health 48 (1981a), pp. 71–79, [INFOTRIEVE][CSA].
  • Buchet, J. P., Lauwerys, R., and Roels, H, 1981b. Urinary excretion of inorganic arsenic and its metabolites after repeated ingestion of sodium metaarsenite by volunteers, Int. Arch. Occup. Environ. Health 48 (1981b), pp. 111–118, [INFOTRIEVE][CSA].
  • Buchet, J. P., Pauwels, J., and Lauwerys, R, 1994. Assessment of exposure to inorganic arsenic following ingestion of marine organisms by volunteers, Environ. Res 66 (1994), pp. 44–51, [INFOTRIEVE][CSA].
  • Buchet, J. P., Lison, D., Ruggeri, M., Foa, V., and Elia, G, 1996. Assessment of exposure to inorganic arsenic, a human carcinogen, due to the consumption of seafood, Arch. Toxicol 70 (1996), pp. 773–778, [INFOTRIEVE][CSA].
  • Calderon, R., Hudgens, E., Le, X. C., Schreinmachers, D., and Thomas, D. J, 1999. Excretion of arsenic in urine as a function of exposure to arsenic in drinking water, Environ. Health Perspect 107 (1999), pp. 663–667, [INFOTRIEVE][CSA].
  • Chango, A., de Courcy, G., Boisson, F., Guilland, J., Barbe, F., Perrin, M., Christides, J., Rabhi, K., Pfister, M., BGalan, P., Hercberg, S., and Nicolas, J, 2000. 5,10-Methylenetetrahydrofolate reductase common mutations, folate status, and plasma homocysteine in healthy French adults of the Supplementation en Vitamines et Mineraux Antioxydants (SU.VI.MAX) cohort, Br. J. Nutr 84 (2000), pp. 891–896, [INFOTRIEVE][CSA].
  • Chen, Y. C., Guo, Y. L., Su, H. J., Hsueh, Y. M., Smith, T. J., Ryan, L. M., Lee, M. S., Chao, S. C., Lee, J. Y., and Christiani, D. C, 2003a. Arsenic methylation and skin cancer risk in southwest Taiwan, J. Occup. Environ. Med 45 (2003a), pp. 241–248, [INFOTRIEVE][CSA].
  • Chen, Y. C., Su, H. J., Guo, Y. L., Hsueh, Y. M., Smith, T. J., Ryan, L. M., Lee, M. S., and Christiani, D. C, 2003b. Arsenic methylation and bladder cancer risk in Taiwan, Cancer Causes Control 14 (2003b), pp. 303–310, [INFOTRIEVE][CSA].
  • Chiou, H. Y., Hsueh, Y. M., Hsieh, L. L., Hsu, L. I., Hsu, Y. H., Hsieh, F. I., Wei, M. L., Chen, H. C., Yang, H. T., Leu, L. C., Chu, T. H., Chen-Wu, C., Yang, M. H., and Chen, C. J, 1997. Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan, Mutat. Res 386 (1997), pp. 197–207, [INFOTRIEVE][CSA].
  • Chung, J. S., Kalman, D. A., Moore, L. E., Kosnett, M. J., Arroyo, A. P., Beeris, M., Mazumder, D. N., Hernandez, A. L., and Smith, A. H, 2002. Family correlations of arsenic methylation patterns in children and parents exposed to high concentrations of arsenic in drinking water, Environ. Health Perspect 110 (2002), pp. 729–733, [INFOTRIEVE][CSA].
  • Concha, G., Volger, G., Nermell, B., and Vahter, M, 2002. Intra-individual variation in the metabolism of inorganic arsenic, Int. Arch. Occup. Environ. Health 75 (2002), pp. 576–580, [INFOTRIEVE][CSA].
  • Crandall, L., and Vorce, R, 2002. Differential effects of arsenic on folate binding protein 2 (Folbp2) null and wild type fibroblasts, Toxicol. Lett 136 (2002), pp. 43–54, [INFOTRIEVE][CSA].
  • Crecelius, E. A, 1978. Modification of the arsenic speciation technique using hydride generation, Anal. Chem 50 (1978), pp. 826–827, [CSA].
  • Csanaky, I., and Gregus, Z, 2005. Role of glutathione in reduction of arsenate and of gamma-glutamyltranspeptidase in disposition of arsenite in rats, Toxicology 207 (2005), pp. 91–104, [INFOTRIEVE][CSA].
  • Cullen, W. R., McBride, B. C., Manji, H., Pickett, A. W., and Reglinski, J, 1989. The metabolism of methylarsine oxide and sulfide, Appl. Organometal. Chem 3 (1989), pp. 71–78, [CSA].
  • Cullen, W., and Reimer, K, 1989. Arsenic speciation in the environment, Chem. Rev 89 (1989), pp. 713–764, [CSA].
  • Curtin, K., Bigler, J., Slattery, M. L., Caan, B., Potter, J. D., and Ulrich, C. M, 2004. MTHFR C677T and A1298C polymorphisms: Diet, estrogen, and risk of colon cancer, Cancer Epidemiol. Biomarkers Prev 13 (2004), pp. 285–292, [INFOTRIEVE][CSA].
  • Davison, K., Cote, S., Mader, S., and Miller, W. H, 2003. Glutathione depletion overcomes resistance to arsenic trioxide in arsenic-resistant cell lines, Leukemia 17 (2003), pp. 931–940, [INFOTRIEVE][CSA].
  • Del Razo, L. M., Garcia-Vargas, G. G., Vargas, H., Albores, A., Gonsebatt, M. E., Montero, R., Ostrosky-Wegman, P., Kelsh, M., and Cebrian, M. E, 1997. Altered profile of urinary arsenic metabolites in adults with chronic arsenicism. A pilot study, Arch. Toxicol 71 (1997), pp. 211–217, [INFOTRIEVE][CSA].
  • Del Razo, L. M., Styblo, M., Cullen, W. R., and Thomas, D. J, 2001. Determination of trivalent methylated arsenicals in biological matrices, Toxicol. Appl. Pharmacol 174 (2001), pp. 282–293, [INFOTRIEVE][CSA].
  • Dresler, C., Fratelli, C., Babb, J., Everley, L., Evans, A., and Clapper, M, 2000. Gender differences in genetic susceptibility for lung cancer, Lung Cancer 30 (2000), pp. 153–160, [INFOTRIEVE][CSA].
  • Edmonds, J., and Francesconi, K, 1993. Arsenic in seafoods: Human health aspects and regulations, Mar. Pollut. Bull 26 (1993), pp. 665–675, [CSA].
  • Egaas, E., Falls, J., and Dauterman, W, 1995. A study of gender, strain and age differences in mouse liver glutathione-S-transferase, Comp. Biochem. Physiol. C Pharmacol. Toxicol. Endocrinol 110 (1995), pp. 35–40, [INFOTRIEVE][CSA].
  • Engel, L., Taioli, E., Pfeiffer, R., Garcia-Closas, M., Marcus, P., and Lan, Q, 2002. Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: A HuGE review, Am. J. Epidemiol 156 (2002), pp. 95–109, [INFOTRIEVE][CSA].
  • Engel, R. R., and Receveur, O, 1993. Re: “Arsenic ingestion and internal cancers: A review.”, Am. J. Epidemiol 138 (1993), pp. 896–897, [INFOTRIEVE][CSA].
  • Feldmann, J., Lai, V. W., Cullen, W. R., Ma, M., Lu, X., and Le, X. C, 1999. Sample preparation and storage can change arsenic speciation in human urine, Clin. Chem 45 (1999), pp. 1988–1997, [INFOTRIEVE][CSA].
  • Foa, V., Colombi, A., Maroni, M., Buratti, M., and Calzaferri, G, 1984. The speciation of the chemical forms of arsenic in the biological monitoring of exposure to inorganic arsenic, Sci. Total Environ 34 (1984), pp. 241–259, [INFOTRIEVE][CSA].
  • Gebel, T. W, 2002. Arsenic methylation is a process of detoxification through accelerated excretion, Int. J. Hyg. Environ. Health 205 (2002), pp. 505–508, [INFOTRIEVE][CSA].
  • Golub, M. S., Macintosh, M. S., and Baumrind, N, 1998. Developmental and reproductive toxicity of inorganic arsenic: Animal studies and human concerns, J. Toxicol. Environ. Health B 1 (1998), pp. 199–241, [CSA].
  • Habif, S., Mutaf, I., Turgan, N., Onur, E., Duman, C., Ozmen, D., and Bayindir, O, 2001. Age and gender dependent alterations in the activities of glutathione related enzymes in healthy subjects, Clin. Biochem 34 (2001), pp. 667–671, [INFOTRIEVE][CSA].
  • Hirata, M., Tanaka, A., Hisanaga, A., and Ishinishi, N, 1990. Effects of glutathione depletion on the acute nephrotoxic potential of arsenite and on arsenic metabolism in hamsters, Toxicol. Appl. Pharmacol 106 (1990), pp. 469–481, [INFOTRIEVE][CSA].
  • Hoensch, H., Morgenstern, I., Petereit, G., Siepmann, M., Peters, W., Roelofs, H., and Kirch, W, 2002. Influence of clinical factors, diet, and drugs on the human upper gastrointestinal glutathione system, Gut 50 (2002), pp. 235–240, [INFOTRIEVE][CSA].
  • Hopenhayn-Rich, C., Smith, A. H., and Goeden, H. M, 1993. Human studies do not support the methylation threshold hypothesis for the toxicity of inorganic arsenic, Environ. Res 60 (1993), pp. 161–177, [INFOTRIEVE][CSA].
  • Hopenhayn-Rich, C., Biggs, M. L., Fuchs, A., Bergoglio, R., Tello, E. E., Nicolli, H., and Smith, A. H, 1996. Bladder cancer mortality associated with arsenic in drinking water in Argentina [published erratum appears in Epidemiology 1997; 8:334], Epidemiology 7 (1996), pp. 117–124, [INFOTRIEVE][CSA].
  • Hsueh, Y. M., Chiou, H. Y., Huang, Y. L., Wu, W. L., Huang, C. C., Yang, M. H., Lue, L. C., Chen, G. S., and Chen, C. J, 1997. Serum beta-carotene level, arsenic methylation capability, and incidence of skin cancer, Cancer Epidemiol. Biomarkers Prev 6 (1997), pp. 589–596, [INFOTRIEVE][CSA].
  • Hughes, M. F., and Kenyon, E. M, 1998. Dose-dependent effects on the disposition of monomethylarsonic acid and dimethylarsinic acid in the mouse after intravenous administration, J. Toxicol. Environ. Health A 53 (1998), pp. 95–112, [INFOTRIEVE][CSA].
  • IARC, 2002. Some drinking-water disinfectants and contaminants, including arsenic. Vol. Volume 84. Lyon: International Agency for Research on Cancer; 2002.
  • Johns, L., and Houlston, R, 2000. Glutathione S-transferase mu1 (GSTM1) status and bladder cancer risk: A meta-analysis, Mutagenesis 15 (2000), pp. 399–404, [INFOTRIEVE][CSA].
  • Le, X. C., Ma, M., Lu, X., Cullen, W. R., Aposhian, H. V., and Zheng, B, 2000. Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine, Environ. Health Perspect 108 (2000), pp. 1015–1018, [INFOTRIEVE][CSA].
  • Lin, J., Spitz, M. R., Wang, Y., Schabath, M. B., Gorlov, I. P., Hernandez, L. M., Pillow, P. C., Grossman, H. B., and Wu, X, 2004. Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: A case-control study, Carcinogenesis 25 (2004), pp. 1639–1647, [INFOTRIEVE][CSA].
  • Lin, S., Cullen, W. R., and Thomas, D. J, 1999. Methylarsenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase, Chem. Res. Toxicol 12 (1999), pp. 924–930, [INFOTRIEVE][CSA].
  • Lin, S., Del Razo, L. M., Styblo, M., Wang, C., Cullen, W. R., and Thomas, D. J, 2001. Arsenicals inhibit thioredoxin reductase in cultured rat hepatocytes, Chem. Res. Toxicol 14 (2001), pp. 305–311, [INFOTRIEVE][CSA].
  • Luten, J. B., Riekwel-Booy, G., and Rauchbaar, A, 1982. Occurrence of arsenic in plaice (Pleuronectes platessa), nature of organo-arsenic compound present and its excretion by man, Environ. Health Perspect 45 (1982), pp. 165–170, [INFOTRIEVE][CSA].
  • Maki-Paakkanen, J., Kurttio, P., Paldy, A., and Pekkanen, J, 1998. Association between the clastogenic effect in peripheral lymphocytes and human exposure to arsenic through drinking water, Environ. Mol. Mutagen 32 (1998), pp. 301–313, [INFOTRIEVE][CSA].
  • Marafante, E., and Vahter, M, 1984. The effect of methyltransferase inhibition on the metabolism of (74) arsenite in mice and rabbits, Chem. Biol. Interact 50 (1984), pp. 49–57, [INFOTRIEVE][CSA].
  • Marafante, E., Vahter, M., and Envall, J, 1985. The role of the methylation in the detoxication of arsenate in the rabbit, Chem. Biol. Interact 56 (1985), pp. 225–238, [INFOTRIEVE][CSA].
  • Marnell, L., Garcia-Vargas, G., Chowdhury, U., Zakharyan, R., Walsh, B., Avram, D., Kopplin, M., Cebrian, M. E., Silbergeld, E., and Aposhian, H. V, 2003. Polymorphisms in the human monomethylarsonic acid (MMAV) reductase/hGSTO1 gene and changes in urinary arsenic profiles, Chem. Res. Toxicol 16 (2003), pp. 1507–1513, [INFOTRIEVE][CSA].
  • Mass, M. J., Tennant, A., Roop, B. C., Cullen, W. R., Styblo, M., Thomas, D. J., and Kligerman, A. D, 2001. Methylated trivalent arsenic species are genotoxic, Chem. Res. Toxicol 14 (2001), pp. 355–361, [INFOTRIEVE][CSA].
  • McDorman, E. W., Collins, B. W., and Allen, J. W, 2002. Dietary folate deficiency enhances induction of micronuclei by arsenic in mice, Environ. Mol. Mutagen 40 (2002), pp. 70–77, [CSA].
  • Meza, M., Yu, L., Rodriguez, Y., Guild, M., Thompson, D., Gandolfi, A., and Klimecki, W, 2005. Developmentally restricted genetic determinants of human arsenic metabolism: Association between urinary methylated arsenic and cyt19 polymorphisms in children, Environ. Health Perspect 13 (2005), pp. 775–781, [CSA].
  • Mitra, S., Guha Mazumder, D., Basu, A., Block, G., Haque, R., Samanta, S., Ghosh, N., Smith, M., von Ehrenstein, O., and Smith, A, 2004. Nutritional factors and susceptibility to arsenic-caused skin lesions in West Bengal, India, Environ. Health Perspect 112 (2004), pp. 1104–1109, [INFOTRIEVE][CSA].
  • Moore, L. E., Wiencke, J. K., Bates, M. N., Zheng, S., Rey, O. A., and Smith, A. H, 2004. Investigation of genetic polymorphisms and smoking in a bladder cancer case-control study in Argentina, Cancer Lett 211 (2004), pp. 199–207, [INFOTRIEVE][CSA].
  • Moore, M. M., Harrington-Brock, K., and Doerr, C. L, 1997. Relative genotoxic potency of arsenic and its methylated metabolites, Mutat. Res 386 (1997), pp. 279–290, [INFOTRIEVE][CSA].
  • National Research Council, 1999. Arsenic in drinking water. Washington, DC: National Research Council; 1999. pp. 229–250, Subcommittee on Arsenic in Drinking Water.
  • Nemeti, B., and Gregus, Z, 2004. Glutathione-dependent reduction of arsenate in human erythrocytes—A process independent of purine nucleoside phosphorylase, Toxicol. Sci 82 (2004), pp. 419–428, [INFOTRIEVE][CSA].
  • Nordstrom, D. K, 2002. Public health. Worldwide occurrences of arsenic in ground water, Science 296 (2002), pp. 2143–2145, [INFOTRIEVE][CSA].
  • Oya-Ohta, Y., Kaise, T., and Ochi, T, 1996. Induction of chromosomal aberrations in cultured human fibroblasts by inorganic and organic arsenic compounds and the different roles of glutathione in such induction, Mutat. Res 357 (1996), pp. 123–129, [INFOTRIEVE][CSA].
  • Petrick, J. S., Ayala-Fierro, F., Cullen, W. R., Carter, D. E., and Aposhian, V. H, 2000. Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes, Toxicol. Appl. Pharmacol 163 (2000), pp. 203–207, [INFOTRIEVE][CSA].
  • Saadat, M., Farvardin-Jahromi, M., and Saadat, H, 2004. Null genotype of glutathione S-transferase M1 is associated with senile cataract susceptibility in non-smoker females, Biochem. Biophys. Res. Commun 319 (2004), pp. 1287–1291, [INFOTRIEVE][CSA].
  • Schmuck, E. M., Board, P. G., Whitbread, A. K., Tetlow, N., Cavanaugh, J. A., Blackburn, A. C., and Masoumi, A, 2005. Characterization of the monomethylarsonate reductase and dehydroascorbate reductase activities of Omega class glutathione transferase variants: Implications for arsenic metabolism and the age-at-onset of Alzheimer's and Parkinson's diseases, Pharmacogenet. Genom 15 (2005), pp. 493–501, [CSA].
  • Seidegard, J., and Pero, R, 1988. The genetic variation and the expression of human glutathione transferase mu, Klin. Wochen 66 (suppl 11) (1988), pp. 125–126, [CSA].
  • Sgambato, A., Campisi, B., Zupa, A., Bochicchio, A., Romano, G., Tartarone, A., Galasso, R., Traficante, A., and Cittadini, A, 2002. Glutathione S-transferase (GST) polymorphisms as risk factors for cancer in a highly homogeneous population in Southern Italy, Anticancer Res 22 (2002), pp. 3647–3652, [INFOTRIEVE][CSA].
  • Shankar, D., Srivastava, L., Kumar, A., Mittal, B., and Mittal, R, 2004. Polymorphism of GSTM1 and GSTT1 genes in bladder cancer: A study from North India, Arch. Toxicol 78 (2004), pp. 430–434, [CSA].
  • Shimizu, M., Hochadel, J. F., Fulmer, B. A., and Waalkes, M. P, 1998. Effect of glutathione depletion and metallothionein gene expression on arsenic-induced cytotoxicity and c-myc expression in vitro, Toxicol. Sci 45 (1998), pp. 204–211, [INFOTRIEVE][CSA].
  • Singal, R., Ferdinand, L., Das, P. M., Reis, I. M., and Schlesselman, J. J, 2004. Polymorphisms in the methylenetetrahydrofolate reductase gene and prostate cancer risk, Int. J. Oncol 25 (2004), pp. 1465–1471, [INFOTRIEVE][CSA].
  • Spiegelstein, O., Le, X., Troen, A., Selhub, J., Melnyk, S., James, S., and Finnell, R, 2003. Effects of dietary folate intake and folate binding protein-1 (Folbp1) on urinary speciation of sodium arsenate in mice, Toxicol. Lett 145 (2003), pp. 167–174, [INFOTRIEVE][CSA].
  • Srivastava, D., Kumar, A., Mittal, B., and Mittal, R, 2004. Polymorphisms of the GSTM1 and GSTT1 genes in bladder cancer: A study from North India, Arch. Toxicol 78 (2004), pp. 430–434, [INFOTRIEVE][CSA].
  • Stegman, K., Ziegler, A., Ngo, E., Kohlschmidt, N., Schroter, B., Ermert, Z., and Koch, M, 1999. Linkage disequilibrium of MTHFR genotypes 677C/T-1298A/C in the German population and association studies in probands with neural tube defects (NTD), Am. J. Med. Genet 5 (1999), pp. 23–29, [CSA].
  • Steinmaus, C., Yuan, Y., Kalman, D., Atallah, R., and Smith, A, 2005. Intra-individual variability in arsenic methylation in a US population, Cancer Epidemiol. Biomarkers Prev 14 (2005), pp. 919–924, [INFOTRIEVE][CSA].
  • Steinmaus, C., Bates, M. N., Yuan, Y., Kalman, D., Atallah, R., Rey, O. A., Biggs, M. L., Hopenhayn, C., Moore, L. E., Hoang, B. K., and Smith, A. H, 2006. Arsenic methylation and bladder cancer risk in case-control studies in Argentina and the United States, J. Occup. Environ. Med 48 (2006), pp. 478–488, [INFOTRIEVE][CSA].
  • Styblo, M., Serves, S., Cullen, W., and Thomas, D, 1997. Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols, Chem. Res. Toxicol 10 (1997), pp. 27–33, [INFOTRIEVE][CSA].
  • Styblo, M., Vega, L., Germolec, D. R., Luster, M. I., Del Razo, L. M., Wang, C., Cullen, W. R., and Thomas, D. J, 1999. "Metabolism and toxicity of arsenicals in cultured cells". In: Chappell, W. R., Abernathy, C. O., and Calderon, R. L., eds. Arsenic: Exposure and health effects. Amsterdam: Elsevier Science; 1999. pp. 311–324.
  • Styblo, M., Del Razo, L. M., Vega, L., Germolec, D. R., LeCluyse, E. L., Hamilton, G. A., Reed, W., Wang, C., Cullen, W. R., and Thomas, D. J, 2000. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells, Arch. Toxicol 74 (2000), pp. 289–299, [INFOTRIEVE][CSA].
  • Styblo, M., Drobna, Z., Jaspers, I., Lin, S., and Thomas, D. J, 2002. The role of biomethylation in toxicity and carcinogenicity of arsenic: A research update, Environ. Health Perspect 110 (suppl. 5) (2002), pp. S767–S771, [CSA].
  • Tang, D., Rundle, A., Warburton, D., Santella, R., Tsai, W., Chiamprasert, S., Hsu, Y., and Perera, F, 1998. Associations between both genetic and environmental biomarkers and lung cancer: Evidence of a greater risk of lung cancer in women smokers, Carcinogenesis 19 (1998), pp. 1949–1953, [INFOTRIEVE][CSA].
  • Ulvik, A., Vollset, S. E., Hansen, S., Gislefoss, R., Jellum, E., and Ueland, P. M, 2004. Colorectal cancer and the methylenetetrahydrofolate reductase 677C → T and methionine synthase 2756A → G polymorphisms: A study of 2,168 case-control pairs from the JANUS cohort, Cancer Epidemiol. Biomarkers Prev 13 (2004), pp. 2175–2180, [INFOTRIEVE][CSA].
  • Vahter, M, 1999a. "Variation in human metabolism of arsenic". In: Chappell, W. R., Abernathy, C. O., and Calderon, R. L., eds. Arsenic: Exposure and health effects. Amsterdam: Elsevier Science; 1999a. pp. 267–279.
  • Vahter, M, 1999b. Methylation of inorganic arsenic in different mammalian species and population groups, Sci. Prog 82 (1999b), pp. 69–88, [INFOTRIEVE][CSA].
  • Vahter, M, 2000. Genetic polymorphism in the biotransformation of inorganic arsenic and its role in toxicity, Toxicol. Lett 112–113 (2000), pp. 209–217, [INFOTRIEVE][CSA].
  • Vahter, M, 2002. Mechanisms of arsenic biotransformation, Toxicology 181 (2002), pp. 211–217, [INFOTRIEVE][CSA].
  • Vahter, M., and Lind, B, 1986. Concentrations of arsenic in urine of the general population in Sweden, Sci. Total Environ 54 (1986), pp. 1–12, [INFOTRIEVE][CSA].
  • Vahter, M., and Marafante, E, 1987. Effects of low dietary intake of methionine, choline, and proteins of the biotransformation of arsenite in the rabbit, Toxicol. Lett 37 (1987), pp. 41–46, [INFOTRIEVE][CSA].
  • Valenzuela, O., Borja-Aburto, V., Garcia-Vargas, G., Cruz–Gonzales, M., Garcia-Montalvo, E., Calderon-Aranda, E., and Del Razo, L, 2005. Urinary trivalent methylated arsenic species in a population chronically exposed to inorganic arsenic, Environ. Health Perspect 113 (2005), pp. 250–254, [INFOTRIEVE][CSA].
  • van der Put, N. M., Gabreels, F., Stevens, E. M., Smeitink, J. A., Trijbels, F. J., Eskes, T. K., van den Heuvel, L. P., and Blom, H. J, 1998. A second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural-tube defects?, Am. J. Hum. Genet 62 (1998), pp. 1044–1051, [INFOTRIEVE][CSA].
  • van Rijnsoever, M., Grieu, F., Elsaleh, H., Joseph, D., and Iacopetta, B, 2005. Characterization of colorectal cancers showing hypermethylation at multiple CpG islands, Gut 51 (2005), pp. 797–802, [CSA].
  • Verma, Y., and Rana, S, 2003. Gender differences in the metabolism of benzene, toluene, and trichloroethylene in rat with special reference to certain biochemical parameters, J. Environ. Biol 24 (2003), pp. 135–140, [INFOTRIEVE][CSA].
  • Weinshilboum, R, 1988. Pharmacogenetics of methylation: Relationship to drug metabolism, Clin. Biochem 21 (1988), pp. 201–210, [INFOTRIEVE][CSA].
  • Weinshilboum, R. M, 1992. Methylation pharmacogenetics: Thiopurine methyltransferase as a model system, Xenobiotica 22 (1992), pp. 1055–1071, [INFOTRIEVE][CSA].
  • Weisberg, I. S., Tran, P., Christensen, B., Sibani, S., and Rozen, R, 1998. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity, Mol. Genet. Metab 64 (1998), pp. 169–172, [INFOTRIEVE][CSA].
  • Wlodarczyk, B., Spiegelstein, O., Gelineau-van Waes, J., Vorce, R. L., Lu, X., Le, C. X., and Finnell, R. H, 2001. Arsenic-induced congenital malformations in genetically susceptible folate binding protein-2 knockout mice, Toxicol. Appl. Pharmacol 177 (2001), pp. 238–246, [INFOTRIEVE][CSA].
  • Wu, Y., Tomon, M., and Sumino, K, 2001. Methylenetetrahydrofolate reductase gene polymorphisms and ischemic stroke: Sex differences in Japanese, Kobe J. Med. Sci 47 (2001), pp. 255–262, [INFOTRIEVE][CSA].
  • Yamauchi, H., and Yamamura, Y, 1984. Metabolism and excretion of orally ingested trimethylarsenic in man, Bull. Environ. Contam. Toxicol 32 (1984), pp. 682–7, [INFOTRIEVE][CSA].
  • Yang, T., and Blackwell, R, 1961. Nutritional and environmental conditions in the blackfoot area, Formosan Sci 15 (1961), pp. 101–129, [CSA].
  • Yu, R. C., Hsu, K. H., Chen, C. J., and Froines, J. R, 2000. Arsenic methylation capacity and skin cancer, Cancer Epidemiol. Biomarkers Prev 9 (2000), pp. 1259–1262, [INFOTRIEVE][CSA].
  • Zhang, J., Zotz, R. B., Li, Y., Wang, R., Kiel, S., Schulz, W. A., Wen, D., Chen, Z., Zhang, L., Wang, S., Gabbert, H. E., and Sarbia, M, 2004. Methylenetetrahydrofolate reductase C677T polymorphism and predisposition towards esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population, J. Cancer Res. Clin. Oncol 130 (2004), pp. 574–580, [INFOTRIEVE][CSA].
  • Zheng, S., Ma, X., Buffler, P., Smith, M., and Wiencke, J, 2001. Whole genome amplification increases the efficacy and validity of buccal cell genotyping in pediatric populations, Cancer Epidemiol. Biomarkers Prev 10 (2001), pp. 697–700, [INFOTRIEVE][CSA].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.